Cargando…
Landscape of costimulatory molecule signature in breast cancer and its prognostic significance
BACKGROUND: Breast cancer (BRCA) is the most common malignant tumor in the world. Because of its substantial heterogeneity, its clinical treatment is faced with various problems. Only a small number of patients can benefit from the treatment of immune checkpoint inhibitor (ICI). Costimulatory molecu...
Autores principales: | Kang, Changyuan, Yun, Fen, Shi, Lin, Jia, Yongfeng, Liu, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929799/ https://www.ncbi.nlm.nih.gov/pubmed/36819560 http://dx.doi.org/10.21037/atm-22-6245 |
Ejemplares similares
-
Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021) -
Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer
por: Huang, Wanze, et al.
Publicado: (2023) -
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022) -
Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018) -
Altered expression of costimulatory molecules in dementias
por: Busse, Stefan, et al.
Publicado: (2021)